Published

Delix Therapeutics: psychedelics without the trip

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Nature Biotechnology
Date: 2022-08-18
Source: OpenAlex
DOI: 10.1038/d41587-022-00006-0
PubMed: 35986098

Authors

Ken Garber

Watch author

Topics and keywords

psilocybin Pharmacology Receptor Pharmacology Other Psilocybin Hallucinogen MDMA Lysergic acid diethylamide Psychology Pharmacology Medicine Serotonin Internal medicine Receptor Psychedelics and Drug Studies

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Delix Therapeutics: psychedelics without the trip2022-08-18

Related papers

PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERSJournal of medical & health sciences review. · 2025-03-10 Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental HealthAdvances in Research · 2023-01-29 Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugsBehavioural Pharmacology · 2021-12-12 MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogensNeuropsychopharmacology · 2020-11-19 Psychedelics for Psychiatric Disorders: More Research NeededPsychiatric News · 2020-04-12 Effects of Psilocybin and Select Pharmaceutical InteractionsMacEwan University Student eJournal · 2026-02-17 International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMADrug and Alcohol Dependence · 2025-01-31 Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and OverviewAmerican Journal of Therapeutics · 2024-02-29